ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    PTC Taste Status and TAS2R38 Genotype as a Possible Indicator for Alcohol Use in Liver Transplant Patients

    A. David, E. Langnas, C. Teperman, B. Gelb, G. Morgan, L. Teperman

    Division of Transplantation, New York University School of Medicine, New York, NY; University of Nebraska, Omaha, NE; Columbia Prep, New York, NY

    Background: Tasting compounds as bitter is genetically determined. Phenylthiocarbamide (PTC) tastes bitter to some or tasteless to others and has been linked to food preference.…
  • 2013 American Transplant Congress

    Impact of CMS CoP on the Selection of Patients and Donor Organs, The

    K. Schnier, V. Sadiraj, J. Cox, N. Turgeon

    Economics, Georgia State University, Atlanta, GA; Emory Transplant Center, Emory University, Atlanta, GA

    Background: SRTR program reports provide detailed information on transplant center performance relative to risk-adjusted expected values. These measures are utilized by the Centers for Medicare…
  • 2013 American Transplant Congress

    Immunosuppression after Renal Allograft Failure: A Survey of US Practices

    G. Bayliss, R. Gohh, P. Morrissey, J. Rodrigue, D. Mandelbrot

    Department of Medicine, Rhode Island Hospital, Providence, RI; Department of Surgery, Rhode Island Hospital, Providence, RI; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA

    Little data exists to guide the management of immunosuppression after renal graft failure. More aggressive tapering of immunosuppressive medications may reduce the risk of infection,…
  • 2013 American Transplant Congress

    Association between Methods of Proteinuria Screening and the Metabolic Syndrome in Potential Living Kidney Donors

    V. Vidyasagar, S. Shah, M. Mohamed, B. Muth, J. Turk, A. Djamali, D. Kaufman, J. Pirsch, D. Foley, J. Mezrich, B. Astor, R. Hofmann

    Dept. of Medicine- Division of Nephrology, University of Wisconsin, Madison; Dept. of Surgery- Division of Transplantation Surgery, University of Wisconsin, Madison

    Background: Proteinuria is a major risk factor for progression in chronic kidney disease. Identification of proteinuria thus may have important implications for kidney donor prognosis…
  • 2013 American Transplant Congress

    Systematic Study of Causes of Death and Allograft Loss in Pancreas Transplantation in the Modern Era with ATG Induction and Tacrolimus Based Triple Immunosuppression

    Y. Kudva, M. Dong, A. Parsaik, W. Kremers, P. Dean, F. Cosio, M. Prieto, M. Stegall

    Endocrinology, Mayo Clinic, Rochester, MN

    Background: Improved surgical techniques, modern immunosuppressive regimens, and a better understanding of donor and recipient risk factors have led to excellent short-term graft survival after…
  • 2013 American Transplant Congress

    Development of Micro Bioscaffold as a Multiplex System To Evaluate Bioactive Molecules That Enhance Cell Function

    B. Wang, A. Jakus, A. Wu, Y. Wu, J. Zhang, R. Shah, J. Wertheim

    Comprehensive Transplant Center, Department of Surgery, Northwestern University, Chicago, IL; Institute for BioNanotechnology in Medicine and Chemistry of Life Processes Institute, Northwestern University, Chicago, IL; Chemistry of Life Processes Institute, Northwestern University, Chicago, IL, Uganda

    Introduction: This study focuses on creating two types of micro biomimetic scaffolds: natural bioscaffold derived from decellularized liver and micron-scale biodegradable polylactide scaffolds infused with…
  • 2013 American Transplant Congress

    Impaired Effector/Memory CD8+ T Cell Response Delays Acute Allograft Rejection in Older Recipients

    A. Elkhal, D. Bedi, C. Denecke, A. Jurisch, I. Kim, T. Heinbokel, H. Li, X. Yuan, X. Ge, S. Tullius

    Surgery, Brigham and Women's Hospital, Boston, MA

    Background: Over the past decade, the proportion of patients over the age of 65, both, waiting for and receiving transplants has increased dramatically. It is…
  • 2013 American Transplant Congress

    Complement Component 3 (C3) Participates in Induction of Myeloid Suppressor Cells

    C. Hsieh, H. Chou, L. Wang, F. Lin, J. Qin, J. Fung, L. Lu, S. Qian

    Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH; General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH; Pathology, Case Western Reserve University, Cleveland, OH

    It was noted that liver transplants in mice are spontaneously accepted, but hepatocyte transplants acutely rejected, suggesting the immunoregulatory activities of liver non-parenchymal cells. We…
  • 2013 American Transplant Congress

    Impact of Deceased Donor Intensive Care Unit Management Parameters on Early Liver Graft Function

    G. Marshall, R. Mangus, A. Tector

    Transplant Division, Dept of Surgery, Indiana University School of Medicine, Indianapolis, IN

    Objective:The Indiana Organ Procurement Organization (IOPO) has adopted deceased donor intensive care unit (ICU) management parameters to optimize placement of transplant organs. It is unknown…
  • 2013 American Transplant Congress

    Prospective, Iterative, Phased, Trial of Proteasome Inhibitor-Based Desensitization in Highly Sensitized Renal Transplant Candidates, A

    E. Woodle, B. Sadaka, R. Walsh, A. Shields, A. Girnita, P. Brailey, R. Alloway, M. Cardi, A. Govil, B. Abu Jawdeh, P. Roy Chaudhury, G. Mogilishetty

    U of Cincinnati, Cincinnati, OH; Hoxworth Blood Center, Cincinnati; Hoxworth Blood Center, Cincinnati; The Christ Hospital, Cincinnati

    Substantive prospective trials of proteasome inhibitor (PI)-based desensitization (DS) have not been reported. This study prospectively evaluated PI-based DS in highly HLA sensitized kidney transplant…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences